These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28454264)

  • 1. Luteolin, a novel p90 ribosomal S6 kinase inhibitor, suppresses proliferation and migration in leukemia cells.
    Deng L; Jiang L; Lin X; Tseng KF; Lu Z; Wang X
    Oncol Lett; 2017 Mar; 13(3):1370-1378. PubMed ID: 28454264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZCL-082, a boron-containing compound, induces apoptosis of non-Hodgkin's lymphoma via targeting p90 ribosomal S6 kinase 1/NF-κB signaling pathway.
    Ma C; Liu M; Zhang J; Cai H; Wu Y; Zhang Y; Ji Y; Shan H; Zou Z; Yang L; Liu L; Xu H; Lei H; Liu C; Zhou L; Cao Y; Zhou H; Wu Y
    Chem Biol Interact; 2022 Jan; 351():109770. PubMed ID: 34861246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1).
    Reipas KM; Law JH; Couto N; Islam S; Li Y; Li H; Cherkasov A; Jung K; Cheema AS; Jones SJ; Hassell JA; Dunn SE
    Oncotarget; 2013 Feb; 4(2):329-45. PubMed ID: 23593654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p90 ribosomal S6 kinase 1 (RSK1) isoenzyme specifically regulates cytokinesis progression.
    Nam HJ; Lee IJ; Jang S; Bae CD; Kwak SJ; Lee JH
    Cell Signal; 2014 Feb; 26(2):208-19. PubMed ID: 24269382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.
    Abdulrahman N; Jaballah M; Poomakkoth N; Riaz S; Abdelaziz S; Issa A; Mraiche F
    Mol Cell Biochem; 2016 Jul; 418(1-2):21-9. PubMed ID: 27236820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin-induced CCAAT/enhancer-binding protein β activation and IL-8/CXCL8 expression via MEKK1, ERK, and p90 ribosomal S6 kinase 1 in lung epithelial cells.
    Lin CH; Nai PL; Bien MY; Yu CC; Chen BC
    J Immunol; 2014 Jan; 192(1):338-48. PubMed ID: 24277696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Clinical Implications of RSK1-3 in Human Breast Cancer.
    Zhao H; Martin TA; Davies EL; Ruge F; Yu H; Zhang Y; Teng XU; Jiang WG
    Anticancer Res; 2016 Mar; 36(3):1267-74. PubMed ID: 26977024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin inhibited proliferation and induced apoptosis of prostate cancer cells through miR-301.
    Han K; Meng W; Zhang JJ; Zhou Y; Wang YL; Su Y; Lin SC; Gan ZH; Sun YN; Min DL
    Onco Targets Ther; 2016; 9():3085-94. PubMed ID: 27307749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RSK-mediated down-regulation of PDCD4 is required for proliferation, survival, and migration in a model of triple-negative breast cancer.
    Cuesta R; Holz MK
    Oncotarget; 2016 May; 7(19):27567-83. PubMed ID: 27028868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation.
    Lee SJ; Kim SG
    Mol Pharmacol; 2006 Jan; 69(1):385-96. PubMed ID: 16246908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RSK1 promotes murine breast cancer growth and metastasis.
    Czaplinska D; Gorska M; Mieczkowski K; Peszynska-Sularz G; Zaczek AJ; Romanska HM; Sadej R
    Folia Histochem Cytobiol; 2018; 56(1):11-20. PubMed ID: 29498411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calreticulin Promotes Proliferation and Migration But Inhibits Apoptosis in Schwann Cells.
    Huang G; Sun Z; Wu J; Shui S; Han X; Guo D; Li T
    Med Sci Monit; 2016 Nov; 22():4516-4522. PubMed ID: 27876711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteolin induces cell cycle arrest and apoptosis through extrinsic and intrinsic signaling pathways in MCF-7 breast cancer cells.
    Park SH; Ham S; Kwon TH; Kim MS; Lee DH; Kang JW; Oh SR; Yoon DY
    J Environ Pathol Toxicol Oncol; 2014; 33(3):219-31. PubMed ID: 25272060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of regulatory events associated with membrane targeting of p90 ribosomal S6 kinase 1.
    Richards SA; Dreisbach VC; Murphy LO; Blenis J
    Mol Cell Biol; 2001 Nov; 21(21):7470-80. PubMed ID: 11585927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rsk1 mediates a MEK-MAP kinase cell survival signal.
    Shimamura A; Ballif BA; Richards SA; Blenis J
    Curr Biol; 2000 Feb; 10(3):127-35. PubMed ID: 10679322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective Targeting of RSK Isoforms in Cancer.
    Casalvieri KA; Matheson CJ; Backos DS; Reigan P
    Trends Cancer; 2017 Apr; 3(4):302-312. PubMed ID: 28718440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RSK1 and RSK2 serine/threonine kinases regulate different transcription programs in cancer.
    Yang WS; Caliva MJ; Khadka VS; Tiirikainen M; Matter ML; Deng Y; Ramos JW
    Front Cell Dev Biol; 2022; 10():1015665. PubMed ID: 36684450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin, a novel natural inhibitor of tumor progression locus 2 serine/threonine kinase, inhibits tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in JB6 mouse epidermis cells.
    Kim JE; Son JE; Jang YJ; Lee DE; Kang NJ; Jung SK; Heo YS; Lee KW; Lee HJ
    J Pharmacol Exp Ther; 2011 Sep; 338(3):1013-22. PubMed ID: 21705614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Luteolin exerts pro-apoptotic effect and anti-migration effects on A549 lung adenocarcinoma cells through the activation of MEK/ERK signaling pathway.
    Meng G; Chai K; Li X; Zhu Y; Huang W
    Chem Biol Interact; 2016 Sep; 257():26-34. PubMed ID: 27474067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
    Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
    Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.